Mutation detection, interpretation, and applications in the clinical laboratory setting
- 3 June 2005
- journal article
- review article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 573 (1-2) , 160-167
- https://doi.org/10.1016/j.mrfmmm.2004.09.017
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Direct Visualization of Cystic Fibrosis Transmembrane Regulator Mutations in the Clinical Laboratory SettingClinical Chemistry, 2004
- Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study GroupJournal of Clinical Oncology, 2004
- Inheritance and Drug ResponseNew England Journal of Medicine, 2003
- CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2Journal of Clinical Endocrinology & Metabolism, 2001
- Clinical relevance of genetic polymorphisms in the human CYP2C subfamilyBritish Journal of Clinical Pharmacology, 2001
- Prevalence of C282Y and H63D Mutations in the Hemochromatosis (HFE) Gene in the United StatesJAMA, 2001
- Analysis of the Factor V Leiden Mutation Using the READIT AssayMolecular Diagnosis, 2001
- The significance of haemochromatosis gene mutations in the general population: implications for screeningGut, 1998
- High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family HistoryGynecologic Oncology, 1997
- Prevalence of Recurring BRCA Mutations Among Ashkenazi Jewish Women with Breast CancerGenetic Testing, 1997